Medicamentos Oncológigos Solución Inyectables
Compra de Medicamentos Oncológicos en Solución Inyectables del Hospital Base Valdivia
9 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 1058134-1356-SE21 | 27-07-2021 | Farmaceutica Insuval S.A. | $435.540 |
| 1058134-1300-SE21 | 23-07-2021 | Fresenius Kabi Chile Limitada | $416.500 |
| 1058134-1227-SE21 | 08-07-2021 | Fresenius Kabi Chile Limitada | $297.500 |
| 1058134-1100-SE21 | 29-06-2021 | Fresenius Kabi Chile Limitada | $595.000 |
| 1058134-1101-SE21 | 29-06-2021 | Farmaceutica Insuval S.A. | $145.180 |
| 1058134-994-SE21 | 04-06-2021 | Fresenius Kabi Chile Limitada | $595.000 |
| 1058134-504-SE21 | 24-03-2021 | Fresenius Kabi Chile Limitada | $416.500 |
| 1058134-1999-SE20 | 16-10-2020 | Farmaceutica Insuval S.A. | $362.950 |
| 1058134-1804-SE20 | 21-09-2020 | Farmaceutica Insuval S.A. | $217.770 |
| 1058134-1379-SE20 | 10-07-2020 | Fresenius Kabi Chile Limitada | $595.000 |
| 1058134-1259-SE20 | 23-06-2020 | Farmaceutica Insuval S.A. | $362.950 |
| 1058134-1258-SE20 | 23-06-2020 | Fresenius Kabi Chile Limitada | $297.500 |
| 1058134-1034-SE20 | 26-05-2020 | Fresenius Kabi Chile Limitada | $119.000 |
| 1058134-994-SE20 | 15-05-2020 | Cegapharma SpA | $4.176.900 |
| 1058134-995-SE20 | 15-05-2020 | Fresenius Kabi Chile Limitada | $297.500 |
| 1058134-651-SE20 | 06-04-2020 | Farmaceutica Insuval S.A. | $435.540 |
| 1058134-419-SE20 | 11-03-2020 | Fresenius Kabi Chile Limitada | $535.500 |
| 1058134-420-SE20 | 11-03-2020 | Farmaceutica Insuval S.A. | $217.770 |
| 1058134-329-SE20 | 11-02-2020 | Cegapharma SpA | $4.176.900 |
| 1058134-95-SE20 | 09-01-2020 | Cegapharma SpA | $4.176.900 |
| 1058134-96-SE20 | 09-01-2020 | Farmaceutica Insuval S.A. | $217.770 |
Fuente original:ficha mercadopublico.cl
